Impotence News and Research RSS Feed - Impotence News and Research

Erectile dysfunction, sometimes called "impotence," is the repeated inability to get or keep an erection firm enough for sexual intercourse. The word "impotence" may also be used to describe other problems that interfere with sexual intercourse and reproduction, such as lack of sexual desire and problems with ejaculation or orgasm. Using the term erectile dysfunction makes it clear that those other problems are not involved.
New study compares sexual experiences linked to alcohol and marijuana use

New study compares sexual experiences linked to alcohol and marijuana use

A new study, published in Archives of Sexual Behavior by researchers affiliated with New York University's Center for Drug Use and HIV Research, compared self-reported sexual experiences related to use of alcohol and marijuana. [More]
Clinicians perform UK’s first MRI-guided focused ultrasound treatment for prostate cancer

Clinicians perform UK’s first MRI-guided focused ultrasound treatment for prostate cancer

INSIGHTEC congratulates the medical team at Imperial College Healthcare NHS Trust for performing the first MR-guided focused ultrasound treatment in the United Kingdom for prostate cancer. [More]
Sonablate HIFU now available in southern California for treatment of prostate cancer patients

Sonablate HIFU now available in southern California for treatment of prostate cancer patients

HIFU Prostate Services, LLC, a leading provider of minimally-invasive prostate cancer treatment using high intensity focused ultrasound, announces that Sonablate HIFU is now available in southern California through a partnership established with Western States HIFU and Pacific Coast Urology and one of the most experienced HIFU physicians in the world, Robert Pugach, MD. [More]
New report focusing on erectile dysfunction from female perspective published by Superdrug Online Doctor

New report focusing on erectile dysfunction from female perspective published by Superdrug Online Doctor

Erectile dysfunction is a common condition that can affect men everywhere, in fact more than half of men aged 40-70 have been affected. [More]
Androgen deprivation therapy for prostate cancer may up Alzheimer's disease risk

Androgen deprivation therapy for prostate cancer may up Alzheimer's disease risk

Men taking androgen deprivation therapy (ADT) for prostate cancer were almost twice as likely to be diagnosed with Alzheimer's disease in the years that followed than those who didn't undergo the therapy, an analysis of medical records from two large hospital systems by Penn Medicine and Stanford University researchers has shown. [More]
PSA screening for prostate cancer drops significantly in middle-aged men

PSA screening for prostate cancer drops significantly in middle-aged men

PSA testing has dropped significantly in middle-aged men after a 2012 recommendation that all men should not be routinely screened for prostate cancer, according to a new study published in the Journal of the American Medical Association. [More]
Johns Hopkins researchers present new healthcare tips from American Heart Association Meeting

Johns Hopkins researchers present new healthcare tips from American Heart Association Meeting

Linking digital activity trackers to smartphones and periodically pinging users with personalized texts that urge them to walk more can significantly increase physical activity levels and spark healthy behavior changes, according to findings of a pilot study conducted at Johns Hopkins. [More]
Addressing quality of life needs in prostate cancer: an interview with Professor Louis Denis

Addressing quality of life needs in prostate cancer: an interview with Professor Louis Denis

Modern patient-directed management is based on optimal, individual medical treatment and holistic personalised patient-centred care. This is certainly true in prostate cancer where most patients are over 60 years of age. They face a negative physical and functional impact from the diagnosis as well as from the treatment with emotional and social challenges. [More]
Gynaecological cancer still remains a taboo subject

Gynaecological cancer still remains a taboo subject

They're thrown into menopause in their twenties, lose the possibility to have biological children, and struggle with their sex life. [More]
UT Arlington, UNTHSC researchers develop user-friendly system alerts for people with sleep apnea

UT Arlington, UNTHSC researchers develop user-friendly system alerts for people with sleep apnea

Masks worn by those with sleep apnea can leak at night and be so uncomfortable that they often drive users away from treatment. But a new system being developed by researchers at UNT Health Science Center and The University of Texas at Arlington could make it easier for the estimated 18 million people with sleep apnea to get a good night's rest. [More]
Gene responsible for cancer growth plays unexpected role in prostate cancer

Gene responsible for cancer growth plays unexpected role in prostate cancer

A gene that is responsible for cancer growth plays a totally unexpected role in prostate cancer. The gene Stat3 is controlled by the immune modulator interleukin 6 and normally supports the growth of cancer cells. The international research team led by Prof. Lukas Kenner from the Medical University of Vienna, the Veterinary University of Vienna, and the Ludwig Boltzmann Institiute for Cancer Research (LBI-CR) discovered a missing link for an essential role of Stat3 and IL-6 signalling in prostate cancer progression. [More]
Allergan announces U.S. availability of SAPHRIS 2.5 mg tablets for children with bipolar I disorder

Allergan announces U.S. availability of SAPHRIS 2.5 mg tablets for children with bipolar I disorder

Allergan plc today announced that SAPHRIS (asenapine) 2.5 mg sublingual (placed under the tongue) black-cherry flavored tablets are available in pharmacies throughout the U.S. In March 2015, the U.S. Food and Drug Administration approved SAPHRIS for the acute treatment of manic or mixed episodes associated with bipolar I disorder in pediatric patients (ages 10 – 17). [More]
Drugs used against impotence does not increase risk of malignant melanoma

Drugs used against impotence does not increase risk of malignant melanoma

Using drugs for impotence does not increase the risk of malignant melanoma, researchers from Umeå University in Sweden conclude in a publication in JAMA, a top US medical journal. These results contradict previous research indicating such an association. [More]
Pathology expert shares vital information about prostate cancer

Pathology expert shares vital information about prostate cancer

Requesting a copy of your pathology report, asking questions of your doctor and playing an active role in decision-making are important ways that men should take control of their health. [More]
Ebola survivors face long-term adverse health effects: Study

Ebola survivors face long-term adverse health effects: Study

Ebola survivors experienced negative health effects that persisted more than two years after the 2007-2008 Bundibugyo ebolavirus (BDBV) outbreak in Uganda that claimed 39 lives. These findings are detailed in a paper published online today in Lancet ID. [More]
Study: Viagra, other related drugs not a universal 'cure-all' for impotence

Study: Viagra, other related drugs not a universal 'cure-all' for impotence

Viagra and other related drugs are not a universal 'cure-all' for impotence, according to a new study from The University of Manchester and NatCen Social Research. [More]
Graphic warning labels can motivate smokers to quit

Graphic warning labels can motivate smokers to quit

Young adults are more likely to appreciate the dangers of smoking when warnings are presented in images as well as text, according to a new study by a Washington State University Vancouver psychologist. [More]
Research opens door to new prostate cancer treatment

Research opens door to new prostate cancer treatment

Researchers from the Centenary Institute’s Origins of Cancer Program have discovered new links between nutrition and prostate cancer. [More]
Scientists examine effect of clothing on preterm babies' behavior

Scientists examine effect of clothing on preterm babies' behavior

Scientists at the Laboratoire éthologie Animale et Humaine (CNRS/Université de Rennes 1), working in collaboration with a neonatologist from Brest University Hospital, observed the effect of preterm babies' clothing on their behavior. Newborns placed in a sleep sack were less active and touched parts of their bodies less frequently than those dressed in a simple bodysuit. [More]
Breakthrough treatment option for men with benign prostatic hyperplasia

Breakthrough treatment option for men with benign prostatic hyperplasia

Men with benign prostatic hyperplasia (BPH), a condition in which the prostate is enlarged but not cancerous, have a new, breakthrough treatment option that is less invasive and has fewer complications than other minimally invasive treatments, such as transurethral resection of the prostate and surgical options, according to research presented at the Society of Interventional Radiology's Annual Scientific Meeting. [More]